Cargando…
Selection of aptamers against triple negative breast cancer cells using high throughput sequencing
Triple-negative breast cancer is the most aggressive subtype of invasive breast cancer with a poor prognosis and no approved targeted therapy. Hence, the identification of new and specific ligands is essential to develop novel targeted therapies. In this study, we aimed to identify new aptamers that...
Autores principales: | Ferreira, Débora, Barbosa, Joaquim, Sousa, Diana A., Silva, Cátia, Melo, Luís D. R., Avci-Adali, Meltem, Wendel, Hans P., Rodrigues, Ligia R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060331/ https://www.ncbi.nlm.nih.gov/pubmed/33883615 http://dx.doi.org/10.1038/s41598-021-87998-y |
Ejemplares similares
-
Potential Capacity of Aptamers to Trigger Immune Activation in Human Blood
por: Avci-Adali, Meltem, et al.
Publicado: (2013) -
Rapid Complexation of Aptamers by Their Specific Antidotes
por: Stoll, Heidi, et al.
Publicado: (2017) -
Upgrading SELEX Technology by Using Lambda Exonuclease Digestion for Single-Stranded DNA Generation
por: Avci-Adali, Meltem, et al.
Publicado: (2009) -
Improving Bioactive Characteristics of Small Diameter Polytetrafluoroethylene Stent Grafts by Electrospinning: A Comparative Hemocompatibility Study
por: Avci-Adali, Meltem, et al.
Publicado: (2023) -
Optimized conditions for successful transfection of human endothelial cells with in vitro synthesized and modified mRNA for induction of protein expression
por: Avci-Adali, Meltem, et al.
Publicado: (2014)